HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adrien Arpel

This article was originally published in The Rose Sheet

Executive Summary

Charles Hoover to president and chief operating officer, succeeding Bary Blank, who will remain chairman and CEO. Hoover will oversee day-to-day operations during the company's "next phase of major growth and strategic development," Adrien Arpel said. He will also "preserve the positive corporate culture that has been developed among the loyal employees during strenuous times." Adrien Arpel (formally Alfin) recently resolved a breach of contract lawsuit with company founder Adrienne Newman ("The Rose Sheet" May 18, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005756

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel